U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962462) titled 'Daily Tadalafil in Diabetic ED Patients' on April 30.
Brief Summary: This study evaluates the effect of 5 mg daily tadalafil therapy on serum levels of Endothelin-1 and E-selectin in diabetic male patients with erectile dysfunction. Outcomes will be compared pre- and post-treatment versus healthy controls.
Study Start Date: May 05
Study Type: INTERVENTIONAL
Condition:
Erectile Dysfunction Associated With Type 2 Diabetes Mellitus
Intervention:
DRUG: Methyl Cellulose Placebo
Oral administration of inert methyl cellulose placebo tablets once daily for 3 months. Used as a comparator in healthy control participants to evaluate chang...